my account  log out
 

Product Name:Celecoxib

Create: 04/17/2018
Expired Date:never
Category: Methacrylate intermediates [Chemical]
Message:Product Name:Celecoxib Another Name:CELEBREX; 4-[[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL]-1H-PYRAZOL-YL]BENZENESULFONAMIDE; 4-[5-((4-METHYLPHENYL)-3-TRIFLUORPMETHYL)-1H-PYRAZOL-YL]BENENESULFONAMIDE; Celecoxib, 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide; Benzenesulfonamide, 4-5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl-; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; Celebra- CAS: Molecular Weight:381.37 Molecular Formula:C17H14F3N3O2S [main adjuvant therapy use] treatment of osteoarthritis, rheumatoid arthritis and familial adenomatous polyposis Another Name:CELEBREX; 4-[[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL]-1H-PYRAZOL-YL]BENZENESULFONAMIDE; 4-[5-((4-METHYLPHENYL)-3-TRIFLUORPMETHYL)-1H-PYRAZOL-YL]BENENESULFONAMIDE; Celecoxib, 4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide; Benzenesulfonamide, 4-5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl-; 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; Celebra- CAS: Molecular Weight:381.37 Molecular Formula:C17H14F3N3O2S [main adjuvant therapy use] treatment of osteoarthritis, rheumatoid arthritis and familial adenomatous polyposis
City:Wuhan Hubei[CN] 
Location:
 
Jun 19 2018 Flunixin meglumin6666622
Jun 19 2018 Flunixin meglumin222224
Jun 19 2018 Flunixin meglumin555322320
Jun 19 2018 Flunixin meglumin56565221
Jun 19 2018 Flunixin meglumin53555222
Jun 19 2018 Flunixin meglumin56562321
Jun 19 2018 Flunixin meglumin5222219
Jun 19 2018 Flunixin meglumin525217
Jun 19 2018 Flunixin meglumin457456419
Jun 19 2018 Flunixin meglumin56+5656519

return back

Copyright © 2012-2017 toextrade Inc. All rights reserved. Contact us